Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2026-01-06 @ 3:44 PM
Study NCT ID:
NCT00694551
Status:
COMPLETED
Last Update Posted:
2019-10-04
First Post:
2008-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MCC-15262
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |